Navigation Links
Gene By Gene Rejects BRCA1/2 Patent Infringement Claims by Myriad and Joins Ambry Genetics to Sue Myriad for Violating Federal Antitrust Laws
Date:8/15/2013

HOUSTON, Aug. 15, 2013 /PRNewswire/ -- Gene By Gene, Ltd. announced that it is teaming with Ambry Genetics to defend against Myriad Genetics' patent infringement lawsuits against both companies in connection with the BRCA1/2 tests being offered by Gene By Gene and Ambry Genetics.  Both companies are also countersuing Myriad for violations of the Federal Antitrust Act.

On June 13, 2013, immediately following the United States Supreme Court's 9-0 landmark decision against Myriad in "Association For Molecular Pathology v. Myriad Genetics," Gene By Gene announced its intention to offer fast, accurate and affordable BRCA1/2 testing to the public.

"The Supreme Court was very clear that gene sequences, even when isolated, cannot be patented," said Gene By Gene President Bennett Greenspan. "In light of this ruling we are pleased that we can now offer Americans the benefit of this more affordable test that we have already successfully offered to overseas clients."

Gene By Gene has been providing BRCA1/2 tests to individuals outside the U.S. since 2012. Those tests are processed at the company's Genomic Research Center in Houston, a CLIA-registered lab.  The company has processed various genetic tests – including BRCA1/2 -- for close to a million individuals and organizations globally.

Yesterday Gene By Gene also filed a declaration with the court outlining the details of its BRCA1/2 test, which it will continue to offer to the public.

Greenspan added, "We look forward to a swift resolution of this litigation to level the playing field for test providers, and to enable greater numbers of people to benefit from the genomics revolution."

About Gene By Gene Ltd.

Founded in 2000, Gene By Gene, Ltd. provides reliable DNA testing, focused on ancestry, health, research and paternity, to a wide range of consumer and institutional customers. Gene By Gene provides DNA tests through its Family Tree DNA division, which pioneered the concept of direct-to­consumer (DTC) testing in the field of genetic genealogy more than a decade ago. Gene By Gene is CLIA registered and through its clinical health division offers regulated diagnostic tests. The Research Use Only (RUO) division serves both DTC and institutional clients worldwide. Gene By Gene offers AABB certified relationship tests through its paternity testing division. The privately held company is headquartered in Houston, which is also home to its state-of-the-art Genomics Research Center.

Media Contact:

For Gene By Gene, Ltd.
Kate Croft
Casteel Schoenborn
croft@csirfirm.com
888-609-8351


'/>"/>
SOURCE Gene By Gene, Ltd.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Court Partially Rejects DOJ "Stay" in Decade-Long Battle for Emergency Contraception Over the Counter
2. Essential Medical Dismisses Patent Case against Masimo and Cercacor
3. Ampio Awarded US and Canadian Patents that will Bolster the Commercialization of Optina™ for the treatment of Diabetic Macular Edema (DME)
4. Inovio Pharmaceuticals Granted U.S. Patent Protection for Synthetic Vaccine for Cervical Dysplasia and Cancer
5. U.S. Patent Office Issues Sixth Patent Covering Zero-Footprint Medical Image Viewers to Heart Imaging Technologies, LLC
6. Biodels Intellectual Property Position Strengthened for Ultra-Rapid-Acting Insulin Programs by Notice of Intent to Grant from European Patent Office
7. DURECT Announces Issuance of U.S. Patents Covering ORADUR® Technology
8. Broad Patent Protection Granted for iBio Immunomodulator
9. Bio-AMD, Inc.; Patent Application for Cartridge Test Cap
10. Coloplast Wins Patent Infringement Verdict Against Generic Medical Devices, Inc.
11. ICU Medical, Inc. Plans to "Vigorously Seek to Collect Damages" in wake of Patent Infringement Victory Over RyMed Technologies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... , June 24, 2016   Pulmatrix, Inc ., ... developing innovative inhaled drugs, announced today that it was ... Investments reconstituted its comprehensive set of U.S. and ... "This is an important milestone for Pulmatrix," said Chief ... shareholder awareness of our progress in developing drugs for ...
(Date:6/23/2016)... 23, 2016 Research and Markets has ... - Forecast to 2022" report to their offering. ... for the patients with kidney failure, it replaces the function ... the patient,s blood and thus the treatment helps to keep ... in balance. Increasing number of ESRD patients ...
(Date:6/23/2016)... June 23, 2016 Roche (SIX: RO, ROG; ... for its Elecsys BRAHMS PCT (procalcitonin) assay as a ... septic shock. With this clearance, Roche is the first ... integrated solution for sepsis risk assessment and management. ... infection and PCT levels in blood can aid clinicians ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... 2016 , ... The temporary closing of Bruton Memorial Library on June 21 due to a ... new, often overlooked aspect of head lice: the parasite’s ability to live away from a ... occurrence, but a necessary one in the event that lice have simply gotten out of ...
(Date:6/25/2016)... ... June 25, 2016 , ... On Friday, June 10, Van ... Wellness at Work award to iHire in recognition of their exemplary accomplishments in worksite ... 7th annual Maryland Workplace Health & Wellness Symposium at the BWI Marriott in Linthicum ...
(Date:6/24/2016)... ... ... was in a crisis. Her son James, eight, was out of control. Prone to extreme ... “When something upset him, he couldn’t control his emotions,” remembers Marcy. “If there was ... other children and say he was going to kill them. If we were driving ...
(Date:6/24/2016)... Rhinebeck, NY (PRWEB) , ... June 24, 2016 , ... Topical BioMedics, Inc, makers of ... of companies that call for a minimum wage raise to $12 an hour by 2020 ... wage. This will restore the lost value of the minimum wage, assure the wage floor ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... actively feeding the Frederick area economy by obtaining investment capital for emerging technology ... past 2½ years that have already resulted in more than a million dollars ...
Breaking Medicine News(10 mins):